Genetic studies on psoriasis with emphasis on the HLA-region. ISBN

Size: px
Start display at page:

Download "Genetic studies on psoriasis with emphasis on the HLA-region. ISBN 91-628-3836-9"

Transcription

1 PUBLICATION LIST A. Thesis Genetic studies on psoriasis with emphasis on the HLA-region. ISBN Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Evidence that HLA-Cw6 determines early onset of psoriasis- obtained using sequence-specific-primers (PCR-SSP). Acta Derm Venereol 1997; 77: Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Samuelsson L, Swanbeck G. Significantly earlier age at onset for the HLA-Cw6 positive than for the Cw6 negative psoriatic sibling. J Invest Dermatol 1997; 22: Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson Å, Martinsson T and Swanbeck G. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families; confirmation of linkage to chromosome 6p (HLA-region), and to 17q, but not to 4q. Human Heredity 1999; 49: Enerbäck C, Enlund F, Inerot A, Samuelsson L, Wahlström J, Swanbeck G, Martinsson T. S gene (corneodesmosin) diversity and its relationship to psoriasis; high content of csnps in the HLA-linked S gene. J Invest Dermatol 2000; 114: Enerbäck C, Enlund F, Inerot A, Samuelsson L, Wahlström J, Swanbeck G, Martinsson T Stronger association to HLA-Cw6 than to corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch Dermatol Res. 2000; 292: Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G, Martinsson T. Cytogenetic analysis of 477 psoriatics revealed an increased frequency of aberrations involving chromosome region 11q. Eur J Hum Genet 1999; 7: B. Other publications 7. Soderpalm B, Andersson G, Enerback C, Engel JA: In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with the brain GABA (A)/benzodiazepine receptor complexes. Neurofarmacology 1997; 36(8), Engel JA, Enerback C, Fahlke C, Hulthe P, Hard E, Johannessen K, Svensson L, Soderpalm B: Serotonergic and dopaminergic involvement in ethanol intake. Novel Pharmacological interventions for alcoholism. Ed Naranjo CA, Sellers EM, Springer Verlag New York, 1992; Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, Yhr M. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133: Swanbeck G, Inerot A, Martinsson T, Enerbäck C, Enlund F, Yhr M, Wahlström J. Genetic counselling in psoriasis. Br J Dermatol.1997; 137:

2 11. Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, Yhr M. Population genetics of psoriasis: Epidemiology, causes and prevention of skin disorders. Ed Grob JJ, Blackwell Science 1997; Enlund F, Samuelsson L, Enerbäck C, Inerot A, Wahlström J, Yhr M, Torinsson Å, Riley J, Swanbeck G, Martinsson T. Psoriasis susceptibility locus in chromosome region 3q21; identified in patients from southwestern Sweden. Eur J Hum Genet 1999; 7: Samuelsson L, Enlund F, Torinsson Å, Yhr M, Inerot A, Enerbäck C, Wahlström J, Swanbeck G, Martinsson T. A genome-wide search for genes predisposing to familial psoriasis; Results from a stratification approach. Hum Genet 1999; 105: O Brien KP, Holm SJ, Nilsson S, Carlen L, Rosenmuller T, Enerback C, Inerot A, Stahle- Backdal M. The HCR gene on 6p21 is unlikely to be a psoriasis susceptibility gene. J Invest Dermatol 2001; 116, Hewett D, Samulesson L, Polding J, Enlund F, Smart D, Cantone CG, See CG, Chadha S, Inerot A, Enerbäck C, Montgomery D, Christodolou C, Robinson P, Matthews P, Plumpton M, Dykes C, Wahlström J, Swanbeck G, Martinsson T, Roses A, Riley J, Purvis I. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 2002; mar 79(3): Enerbäck C, Porter DA, Seth P, Sgroi D, Weremowicz S, Morton CC, Schnitt S, Polyak K. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 2002; jan 1; 62(1): Martinsson H, Yhr M, Enerbäck C: Expression patterns of S100A7 (Psoriasin) and S100A9 (Calgranulin B) in keratinocyte differentiation. Exp Dermatol 2005;14(3): Carlsson H, Yhr M, Petersson S, Collins N, Polyak K, Enerbäck C: S100A7 and A100A9 induction are dependent on reactive oxygen species and are downregulated by Bcl-2 and antioxidants. Cancer Biol Ther Sep;4(9): Carlsson H, Petersson S and Enerbäck C. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development Int J Oncology 2005 Dec;27(6): Krop I, März A, Carlsson H, Li X, Qimron N, Gelman R, Schnitt S, Kleer C, Enerbäck C, Polyak K: A putative role for psoriasin in breast tumor progression. Cancer Res 2005 Dec 15;65(24): Inerot A, Enerbäck C, Enlund F, Martinsson T, Samuelsson L, Wahlström J, Swanbeck G. Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatology 2005, 5: Petersson S, Bylander A, Yhr M, Enerbäck C. S100A7 (Psoriasin), highly expressed in Ductal Carcinoma In Situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells. BMC Cancer 2007, 7:205.

3 23. Erlandson A, Appelqvist F, Wennberg AM, Holm J, Enerbäck C. Novel CDKN2A mutations detected in Western Swedish families with Hereditary Malignant Melanoma. J Invest Dermatol 2007 Jun;127: Erlandsson E, Appelqvist F, Enerbäck C: Epigenetic mutations in CDKN2A in western Swedish families with hereditary malignant melanoma. Molecular medicine reports 1: 89-91, Anderson K, Wong J, Polyak K, Aronzon D and Enerbäck C. Detection of psoriasin/s100a7 in the sera of patients with psoriasis. Br J Dermatol 2009;160(2): Petersson S, Shubbar E, Enerbäck L, Enerbäck C. Expression of S100 proteins in the progression of melanocytic lesions. Melanoma Research 2009 Aug;19(4): Carén H, Erichsen J, Enerbäck C, Olsson L, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses and MLPA for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008: 29;9: Petersson S, Shubbar E, Yhr M, Kovacs A, Enerbäck C. Loss of ICAM1 signalling induces psoriasin and MUC1 expression in mammary epithelial cells. Breast Cancer Res Treat in press. 29. Öfverholm A, Einbeigi Z, Albertsson P, Skrtic S and Enerbäck C. Association of the MDR1 C3435T variation with paclitaxel-induced neurotoxicity. Oncology letters 1: , Einbeigi Z, Enerbäck C, Karlsson P, Nordling M, Wallgren A: BRCA1 gene mutations may explain more than 80 per cent of excess number of ovarian cancer cases after breast cancer -a population based study from the Western Sweden Health region. Acta Oncol Feb Öfverholm A, Arkblad A, Skrtic S, Albertsson P, Shubbar E, Enerbäck C: Two cases of 5- fluorouracil toxicity linked with gene variants in the DPYD gene. Clin Biochem Feb;43(3): Anderson K, Petersson S, Wong J, Shubbar E, Lokko, Carlström M and Enerbäck C. Elevation of serum EGF, TNF-alpha, and IL-1Ra in active psoriasis vulgaris. Submitted. 33. Shubbar E, Nilsson J, Petersson S, Enerbäck C. Psoriasin is correlated with increased expression of VEGF, RAGE and endothelial cells proliferation. In manuscript.

4 C. Abstract 1. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Evidence that HLA-Cw6 determines early onset of psoriasis- obtained using sequence-specific-primers (PCR-SSP) / i Laugarvatn, Island : The 5th workshop of the Nordic Genome Initiative 2. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. HLA-Cw6 determines early onset of Swedish psoriatics- obtained using sequence-specific primers (PCR-SSP) 29/10-2/ i San Fransisco, USA: The American Society of Human Genetics, 46th annual meeting 3. Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Swanbeck G. Betydelsen av HLA-Cw6 för debutåldern vid psoriasis. Läkarstämman, Stockholm Enerbäck C, Martinsson T, Inerot A, Wahlström J, Enlund F, Yhr M, Samuelsson L, Swanbeck G. Different age at onset for psoriatic siblings discordant for the presence of Cw6 at the HLA-C locus. 28/10-1/ i Baltimore, USA: The American Society of Human Genetics, 47th annual meeting. 5. Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. Cytogenetic analysis of 477 Swedish psoriasis patients. 27/10-30/ i Denver USA: The American Society of Human Genetics, 48th annual meeting. 6. Enerbäck C, Holmqvist D, Inerot A, Enlund F, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. Cytogenetisk analys av 477 psoriasispatienter. Läkarstämman, Göteborg Enerbäck C, Staffan Nilsson, Enlund F, Inerot A, Samuelsson L, Torinsson Å, Wahlström J, Swanbeck G and Martinsson T. HLA-Cw6 is the primary association for psoriasis in the HLA region based on TDT analysis. 19/10-23/ i San Fransisco, USA: The American Society of Human Genetics, 49th annual meeting. 8. Enerbäck C: Autoreferat av avhandling. Läkarstämman Stockholm Carlsson C, Petersson S, Enerbäck C. Psoriasin induction correlate to VEGF expression. American Association for Cancer Research, AACR, Washington 1/4-5/ Petersson S, Bylander A, Enerbäck C. S100A7 (Psoriasin) is regulated by IFN-gamma in mammary epithelial cells. Advances in breast cancer research, AACR, San Diego 10-15/ Petersson S, Shubbar, Enerbäck C. Expression of S100 proteins in the progression of melanocytic lesions. European association for cancer research Lyon 5-8/ Carén H, Erichsen J, Enerbäck C, Olsson L, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses and MLPA for detection of

5 deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene. 13. Advances in breast cancer research, AACR, San Diego 10-15/

Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris

Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris 대 한 건 선 학 회 지 제 5 권, 제 1 호 Journal of the Korean Society for Psoriasis Vol. 5, No. 1, 43-47, 2008 Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris Sang Eun Lee, M.D., Jung Eun Lee,

More information

Phenotypes and Classification of Psoriasis

Phenotypes and Classification of Psoriasis Rheumatology 2010 Birmingham 21 April 2010 Phenotypes and Classification of Psoriasis Christopher E.M. Griffiths Abbott Centocor Incyte Galderma Janssen-Cilag Leo Pharma Lynxx Novartis Pfizer Schering-Plough

More information

BRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS

BRCA1 and BRCA2. BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 BRCA1 and BRCA2 Clinician Guide KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS BRCA1 and BRCA2 Breast cancer is the most common cancer in women, diagnosed in

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome Thomas Wiesner Disclosure Listed as co-inventor US patent application US 61/463,389 BAP1 mutational analysis in determining susceptibility

More information

A powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches

A powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches A powerful model of endometrial carcinogenesis! molecular analysis and rational design of immunological intervention approaches Afrouz Behboudi PhD, Associate Prof. School of Life Sciences, University

More information

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of 1 HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study Lotus Mallbris, MD, PhD, Katarina Wolk, MD, Fabio Sánchez

More information

Progress and Prospects in Ovarian Cancer Screening and Prevention

Progress and Prospects in Ovarian Cancer Screening and Prevention Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian

More information

Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress

Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress Lung Cancer Accounts for 14% of All New Cancer Diagnoses in the United States 1 Lung cancer is the second most common malignancy

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to provide guidance to providers enrolled in the Connecticut Medical Assistance Program (CMAP) on the requirements for

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013

Hereditary Ovarian cancer: BRCA1 and BRCA2. Karen H. Lu MD September 22, 2013 Hereditary Ovarian cancer: BRCA1 and BRCA2 Karen H. Lu MD September 22, 2013 Outline Hereditary Breast and Ovarian Cancer (HBOC) BRCA1/2 genes How to identify What it means to you What it means to your

More information

psoriasis - A New Frontier in Metastatiology

psoriasis - A New Frontier in Metastatiology Arch Immunol Ther Exp, 2005, 53, 428 433 PL ISSN 0004-069X WWW.AITE ONLINE.ORG Review Received: 2004.12.13 Accepted: 2005.03.14 Published: 2005.10.15 Human leukocyte antigens as psoriasis inheritance and

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011 Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: May 2015 Policy No: 02 Effective Date:

More information

Genetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2)

Genetic Testing for Susceptibility to Breast and Ovarian Cancer (BRCA1 and BRCA 2) Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Dal germinale al somatico nella identificazione di tumori ereditari

Dal germinale al somatico nella identificazione di tumori ereditari Modena 18-19 novembre 2010 Dal germinale al somatico nella identificazione di tumori ereditari Laura Ottini Tendencies to develop cancer can be inherited Fletcher & Houlston, 2010 Cancer is a genetic disease

More information

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t

More information

Genetics of Rheumatoid Arthritis Markey Lecture Series

Genetics of Rheumatoid Arthritis Markey Lecture Series Genetics of Rheumatoid Arthritis Markey Lecture Series Al Kim akim@dom.wustl.edu 2012.09.06 Overview of Rheumatoid Arthritis Rheumatoid Arthritis (RA) Autoimmune disease primarily targeting the synovium

More information

The Human Genome Project

The Human Genome Project The Human Genome Project Brief History of the Human Genome Project Physical Chromosome Maps Genetic (or Linkage) Maps DNA Markers Sequencing and Annotating Genomic DNA What Have We learned from the HGP?

More information

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How

More information

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center

Hereditary Breast Cancer. Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Hereditary Breast Cancer Nicole Kounalakis, MD Assistant Professor of Surgery University of Colorado Medical Center Outline Background Assessing risk of patient Syndromes BRCA 1,2 Li Fraumeni Cowden Hereditary

More information

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010

BRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations

More information

Sequencing and microarrays for genome analysis: complementary rather than competing?

Sequencing and microarrays for genome analysis: complementary rather than competing? Sequencing and microarrays for genome analysis: complementary rather than competing? Simon Hughes, Richard Capper, Sandra Lam and Nicole Sparkes Introduction The human genome is comprised of more than

More information

Fulfilling the Promise

Fulfilling the Promise Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,

More information

Collaborative Association Study of Psoriasis. Gonçalo Abecasis, Anne Bowcock, James Elder, Jerry Krueger

Collaborative Association Study of Psoriasis. Gonçalo Abecasis, Anne Bowcock, James Elder, Jerry Krueger Collaborative Association Study of Psoriasis Gonçalo Abecasis, Anne Bowcock, James Elder, Jerry Krueger Psoriasis Chronic, inflammatory skin condition Characteristic lesions, can affect substantial proportion

More information

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong ORIGINAL ARTICLES Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong Drs. C. W. Fung, L.Y. Chong, C.Y. Leung, C. N. Look, K.K. Lo, K. M. Ho Social Hygiene Service

More information

Human Genome Organization: An Update. Genome Organization: An Update

Human Genome Organization: An Update. Genome Organization: An Update Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion

More information

PREPARED FOR: U.S. Army Medical Research and Materiel CommandFort Detrick, Maryland 21702 5012

PREPARED FOR: U.S. Army Medical Research and Materiel CommandFort Detrick, Maryland 21702 5012 AD Award Number: W81XWH 07 1 0542 TITLE: Is Nuclear Structure Altered in Breast Cancer Cells? PRINCIPAL INVESTIGATOR: Han Htun, Ph.D. CONTRACTING ORGANIZATION: University of California Los Angeles, CA

More information

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland

More information

Information leaflet. Centrum voor Medische Genetica. Version 1/20150504 Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel

Information leaflet. Centrum voor Medische Genetica. Version 1/20150504 Design by Ben Caljon, UZ Brussel. Universitair Ziekenhuis Brussel Information on genome-wide genetic testing Array Comparative Genomic Hybridization (array CGH) Single Nucleotide Polymorphism array (SNP array) Massive Parallel Sequencing (MPS) Version 120150504 Design

More information

An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip

An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip Joints Introduction Maezawa et al., have reported that

More information

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network

More information

Targeted Therapy in an Era of Genomic Medicine. George W. Sledge MD Stanford University

Targeted Therapy in an Era of Genomic Medicine. George W. Sledge MD Stanford University Targeted Therapy in an Era of Genomic Medicine George W. Sledge MD Stanford University Why Do Women Die of Breast Cancer? Bad biology Avoidable deaths Important subsets of breast cancers defined by molecular

More information

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental

More information

Outline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice

Outline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment Radiation Biology Outline Introduction: Predictive assays in radiation therapy Examples for specific tumors Immunotherapy Summary

More information

Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms

Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms Antigenic variation in Plasmodium falciparum : Erythrocyte invasion and immune escape mechanisms Introduction Why does immunity to malaria take so long to develop? The parasite s survival depends on its

More information

Publikationsliste Claudia Götz

Publikationsliste Claudia Götz Publikationsliste Claudia Götz 1. Reinhard,B., Götz, C., and Faillard, H.: Synthesis of N-Acetyl-9-Oacetylneuraminic acid α-p-aminophenylthioketoside and its application as ligand in the affinity chromatography

More information

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of

More information

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

HER2 Status: What is the Difference Between Breast and Gastric Cancer? Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC

More information

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service

Understanding Hereditary Breast and Ovarian Cancer. Maritime Hereditary Cancer Service Understanding Hereditary Breast and Ovarian Cancer Maritime Hereditary Cancer Service General Information Cancer is very common. About one in three (33%) people are diagnosed with some form of cancer during

More information

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center Hereditary Multifocal Breast Cancer Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center CASE STUDY 30 year old Ashkenazi Jewish woman Nulliparous Felt

More information

PART 3.3: MicroRNA and Cancer

PART 3.3: MicroRNA and Cancer BIBM 2010 Tutorial: Epigenomics and Cancer PART 3.3: MicroRNA and Cancer Dec 18, 2010 Sun Kim at Indiana University Outline of Part 3.3 Background on microrna Role of microrna in cancer MicroRNA pathway

More information

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer

Nancy E. Davidson, MD Johns Hopkins University. Breast Cancer This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes Becoming a cancer cell isn t easy One of the fundamental molecular characteristics of cancer is that it does not develop all at once, but

More information

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women

More information

Hereditary diffuse gastric cancer and genetic syndromes of stomach cancer: What clinicians need to know

Hereditary diffuse gastric cancer and genetic syndromes of stomach cancer: What clinicians need to know Hereditary diffuse gastric cancer and genetic syndromes of stomach cancer: What clinicians need to know Fátima Carneiro IPATIMUP & Medical Faculty/Centro Hospitalar São João Porto, Portugal IPATIMUP FMUP/CHSJ

More information

Guideline Development The American Society of Clinical Oncology

Guideline Development The American Society of Clinical Oncology Assessing Genomic Sequencing Information for Health Care Decision Making Decision Making Once Evidence is Assessed/Graded Evaluated Guideline Development The American Society of Clinical Oncology Gary

More information

ITT Advanced Medical Technologies - A Programmer's Overview

ITT Advanced Medical Technologies - A Programmer's Overview ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

Translocation Renal Cell Carcinomas

Translocation Renal Cell Carcinomas Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer

More information

Electronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project

Electronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project 1999 Oxford University Press Nucleic Acids Research, 1999, Vol. 27, No. 1 99 105 Electronic access to mouse tumor data: the Mouse Tumor Biology Database (MTB) project Carol J. Bult*, Debra M. Krupke and

More information

Information Exchange and Data Transformation (INFORMED) Initiative

Information Exchange and Data Transformation (INFORMED) Initiative Information Exchange and Data Transformation (INFORMED) Initiative Sean Khozin, MD, MPH Senior Medical Officer Office of Hematology and Oncology Products (OHOP) Food and Drug Administration (FDA) The opinions

More information

GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP

GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP GENETIC CONSIDERATIONS IN CANCER TREATMENT AND SURVIVORSHIP WHO IS AT HIGH RISK OF HEREDITARY CANCER? Hereditary Cancer accounts for a small proportion of all cancer or approximately 5-10% THE DEVELOPMENT

More information

Cancer: Genetic testing can save lives

Cancer: Genetic testing can save lives Cancer: Genetic testing can save lives Track chances of having a tumor's tendency among people with a history of disease cases in the family, but practice should not be trivialized and hurt even more who

More information

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC

More information

Ovarian Cancer Genetic Testing: Why, When, How?

Ovarian Cancer Genetic Testing: Why, When, How? Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine

More information

Breast cancer and the role of low penetrance alleles: a focus on ATM gene

Breast cancer and the role of low penetrance alleles: a focus on ATM gene Modena 18-19 novembre 2010 Breast cancer and the role of low penetrance alleles: a focus on ATM gene Dr. Laura La Paglia Breast Cancer genetic Other BC susceptibility genes TP53 PTEN STK11 CHEK2 BRCA1

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Genome Scans For Genetic Predisposition To Alcoholism By Use Of Transmission Disequilibrium Test Analyses

Genome Scans For Genetic Predisposition To Alcoholism By Use Of Transmission Disequilibrium Test Analyses Genetic Epidemiology 17(Suppl 1): S277-S281 (1999) Genome Scans For Genetic Predisposition To Alcoholism By Use Of Transmission Disequilibrium Test Analyses Grier P. Page, Terri M. King, Jill S. Barnholtz,

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer Contents Introduction: biology and medicine, two separated compartments What we need to know: - boring basics in DNA/RNA structure and overview of particular aspects of molecular biology techniques - How

More information

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers J. Appl. Genet. 44(3), 2003, pp. 419-423 Short communication Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers Bohdan GÓRSKI,

More information

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,

More information

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany

More information

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/

More information

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1) Verónica Cánovas, PhD Student Laboratory of Cell Signalling and Cancer Progression, Dra. Rosanna Paciucci

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

Tumour necrosis factor-a polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis

Tumour necrosis factor-a polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis Rheumatology 2002;41:525 530 Tumour necrosis factor-a polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis A. M. Al-Heresh, J. Proctor 1,S.M.Jones,J.Dixey,B.Cox, K. Welsh 1 and N. McHugh Royal

More information

Office of Population Health Genomics

Office of Population Health Genomics Office of Population Health Genomics Policy: Protocol for the management of female BRCA mutation carriers in Western Australia Purpose: Best Practice guidelines for the management of female BRCA mutation

More information

How Can Institutions Foster OMICS Research While Protecting Patients?

How Can Institutions Foster OMICS Research While Protecting Patients? IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice

More information

Globally, about 9.7% of cancers in men are prostate cancers, and the risk of developing the

Globally, about 9.7% of cancers in men are prostate cancers, and the risk of developing the Chapter 5 Analysis of Prostate Cancer Association Study Data 5.1 Risk factors for Prostate Cancer Globally, about 9.7% of cancers in men are prostate cancers, and the risk of developing the disease has

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology

More information

Mesothelioma. Mesothelioma and Asbestos 11/21/2009

Mesothelioma. Mesothelioma and Asbestos 11/21/2009 Mesothelioma Michele Carbone, M.D.,PH.D. Director Cancer Research Center of Hawaii Professor and Chairman, Dept. of Pathology J.A. Burns Medical School University of Hawaii Honolulu, HI 96813 Mesotheliomas

More information

Risk Assessment and Screening Tools November 17, 2010

Risk Assessment and Screening Tools November 17, 2010 Risk Assessment and Screening Tools November 17, 2010 Cecelia Bellcross Posted in the Resource Repository at: http://www.resourcerepository.org/documents/2073/riskassessmentandscreeningtool s/ Cecelia

More information

The EGFR mutation and precision therapy for lung cancer

The EGFR mutation and precision therapy for lung cancer for lung cancer Outcomes in advanced lung cancer have seen meaningful improvement in the past decade thanks to new precision drug therapies. Because tumors usually develop resistance to the drugs, scientists

More information

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST NOTTINGHAM BREAST INSTITUTE BREAST AND OVARIAN FAMILY HISTORY GUIDELINES GP Referrals All GP referrals for asymptomatic women with a family history of breast and/or

More information

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur

More information

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.

More information

MEDICAL GENETICS GENERAL OBJECTIVE SPECIFIC OBJECTIVES

MEDICAL GENETICS GENERAL OBJECTIVE SPECIFIC OBJECTIVES SUBJECT MEDICAL GENETICS CREDITS Total: 4.5 Theory 2.5 Practical 2 GENERAL OBJECTIVE To provide students with terminology and knowledge from the field of human genetics that will enable them to understand

More information

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS -

Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - Genetic Testing for Hereditary Breast and Ovarian Cancer - BRCA1/2 ANALYSIS - January 2005 SCIENTIFIC BACKGROUND Breast cancer is considered to be one of the most prevalent cancer in women. The overall

More information

Forensic DNA Testing Terminology

Forensic DNA Testing Terminology Forensic DNA Testing Terminology ABI 310 Genetic Analyzer a capillary electrophoresis instrument used by forensic DNA laboratories to separate short tandem repeat (STR) loci on the basis of their size.

More information

M110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics

M110.726 The Nucleus M110.727 The Cytoskeleton M340.703 Cell Structure and Dynamics of Biochemistry and Molecular Biology 1. Master the knowledge base of current biochemistry, molecular biology, and cellular physiology Describe current knowledge in metabolic transformations conducted

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center

More information

Histologic Subtypes of Renal Cell Carcinoma

Histologic Subtypes of Renal Cell Carcinoma Histologic Subtypes of Renal Cell Carcinoma M. Scott Lucia, MD Associate Professor Chief of Genitourinary and Renal Pathology Director, Prostate Diagnostic Laboratory Dept. of Pathology University of Colorado

More information

Normal values of IGF1 and IGFBP3. Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A.

Normal values of IGF1 and IGFBP3. Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A. Normal values of IGF1 and IGFBP3 Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A. Agenda of the presentation IGF1 and IGFBP3 basic characteristic Why normal values Groups of the persons and

More information

MOLECULAR GENETICS OF PSORIASIS. Kati Asumalahti

MOLECULAR GENETICS OF PSORIASIS. Kati Asumalahti HELSINKI UNIVERSITY BIOMEDICAL DISSERTATIONS, No. 27 Helsinki Biomedical Graduate School Department of Medical Genetics University of Helsinki Finland MOLECULAR GENETICS OF PSORIASIS Kati Asumalahti Academic

More information

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification

More information

A23: Oncologic Disease- Tumor Markers

A23: Oncologic Disease- Tumor Markers A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of

More information

Riesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid

Riesgo genético y familiar. Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid Riesgo genético y familiar Javier Benitez Centro Nacional Investigaciones Oncológicas Madrid Cancer: An example of complex disease 80-85% of cancers Polygenic model (combination of X genes) Low penetrance

More information